Image pharmaphorum Editor Sales & Marketing Sponsored Pharma’s New Frontier MSLs are in prime position to build new structures of engagement as the pharma industry recalibrates after the disruptive force of the pandemic. Patients Fatty liver disease: With little early detection, more chall... For most of my adult life, I had been the typical American fat guy, gaining a pound or two a year and thinking little of it. Spotlight on Frontiers Health 2022 As the healthcare industry emerges at last from the COVID-19 pandemic into a new, digitally supercharged world, stakeholders across the industry must move fast to embrace digital transforma R&D How Pharmacogenomics may finally realise its promise More than 60 percent of a Load more results
Sales & Marketing Sponsored Pharma’s New Frontier MSLs are in prime position to build new structures of engagement as the pharma industry recalibrates after the disruptive force of the pandemic.
Patients Fatty liver disease: With little early detection, more chall... For most of my adult life, I had been the typical American fat guy, gaining a pound or two a year and thinking little of it.
Spotlight on Frontiers Health 2022 As the healthcare industry emerges at last from the COVID-19 pandemic into a new, digitally supercharged world, stakeholders across the industry must move fast to embrace digital transforma
Patients Making direct-to-patient work, with Matt Wadyka Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
